GH Research (GHRS) EBT (2020 - 2026)
GH Research (GHRS) posted quarterly EBT of -$14.1 million for Q4 2025, down 60.61% year-over-year from -$35.9 million in Q4 2024, and down 0.83% quarter-over-quarter from -$14.0 million in Q3 2025.
Analysis
GH Research (GHRS) EBT (2020 - 2026) Analysis & Trends
GH Research's EBT history runs 6 years deep, the most recent figure standing at -$14.1 million for Q4 2025.
- In Q4 2025, EBT fell 60.61% year-over-year to -$14.1 million; the TTM figure through Dec 2025 stood at -$48.3 million (down 23.86% YoY), while the FY2025 annual figure was -$48.3 million, down 23.86% from the prior year.
- EBT for Q4 2025 stood at -$14.1 million, down from -$14.0 million in the prior quarter.
- The five-year high for EBT was $334000.0 in Q2 2022, with the low at -$23.2 million in Q4 2022.
- The 5-year median for EBT is -$9.0 million (2024), against an average of -$8.4 million.
- The sharpest annual moves came in 2021 and 2022: EBT slumped 3036.62% in 2021, then surged 115.72% in 2022.
- GH Research's EBT stood at -$10.2 million in 2021, then plunged by 127.19% to -$23.2 million in 2022, then soared by 51.33% to -$11.3 million in 2023, then advanced by 21.91% to -$8.8 million in 2024, then plunged by 60.61% to -$14.1 million in 2025.
- Business Quant data shows GHRS's EBT at -$14.1 million in Q4 2025, -$14.0 million in Q3 2025, and -$9.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 542.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -767.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 312.46 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -11.37 Mn |
| 10 | GH Research | 1.70 Bn | 1.34 Bn | - | -15.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.15 Mn |
| Mar 31, 2026 | -18.97 Mn |
| Dec 31, 2025 | -14.14 Mn |
| Sep 30, 2025 | -14.02 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | -10.81 Mn |
| Dec 31, 2024 | -8.80 Mn |
| Sep 30, 2024 | -12.11 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -7.67 Mn |
| Dec 31, 2023 | -11.27 Mn |
| Sep 30, 2023 | -5.65 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -10.94 Mn |
| Dec 31, 2022 | -16.59 Mn |
| Sep 30, 2022 | -441,000.00 |
| Jun 30, 2022 | 334,000.00 |
| Mar 31, 2022 | -5.76 Mn |
| Dec 31, 2021 | -4.09 Mn |
| Sep 30, 2021 | -1.84 Mn |